Regulation 16 Other actions relating to shared information

(1)

If information shared under regulation 15 by a responsible body with another body that is a designated body (DB) shows a concern about the inappropriate or unsafe management or use of controlled drugs by a person who is or who could become as regards DB a relevant individual (RI), paragraph (2) applies.

(2)

The accountable officer of the DB may—

(a)

make recommendations to any responsible body (including any DB) as to any action that the accountable officer considers that the responsible body should take in relation to RI to protect the safety of patients and the general public; and

(b)

in connection with doing so, share information about the concern with that responsible body.

(3)

If information is shared under regulation 15 with a local lead CDAO about a person (P) who—

(a)

is a relevant person—

(i)

in England, as regards F1NHS England, or

(ii)

in Scotland, as regards the local lead CDAO's Health Board; and

(b)

is not providing services to a designated body as a relevant individual in the area of the local lead CDAO's local intelligence network,

paragraph (4) applies.

(4)

The local lead CDAO must take all reasonable steps to protect the safety of patients or the general public in connection with, or in connection with the possibility of, P engaging in relevant activities, including where appropriate—

(a)

referral of the matter to a responsible body (for example a regulatory body or a police force); and

(b)

sharing of information about P with any person or a representative of any body (including at a meeting of a local intelligence network of which that person or representative is not a part) who employs or may employ P in relevant activities.

Annotations

Textual amendments

F1: Words in Regulations substituted (6.11.2023) by The Health and Care Act 2022 (Further Consequential Amendments) (No. 2) Regulations 2023 (S.I. 2023/1071), reg. 1(1), Sch. para. 1